Cannabis Law Report

NOVEMBER 17, 2022

This collaboration ensures first-of-their-kind consistent cannabinoid compositions for 575 DEA-licensed cannabis medical research institutions developing cures for PTSD, pain management, anxiety conditions and more Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp.

Pharmaceutical 52

Pharmaceutical Research and Development DEA Cannabinoids 52

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Pharmaceutical 76

Pharmaceutical Research and Development Sativa Extraction 76

Cannabis Info

OCTOBER 4, 2019

The Scientist Who Identified THC Is Now Working on Synthetic Cannabinoids. Dr. Raphael Mechoulam , the scientist who first recognized the THC molecule in 1965, introduced his latest mission in California final week: constructing artificial cannabinoids. The plant produces a group of compounds called cannabinoid acids.

Cannabinoids 45

Cannabinoids THC Wellness and Beauty Research and Development 45

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

MedicalJane

MAY 14, 2020

As a result, research on the health effects of cannabis and cannabinoids has been limited in the United States, leaving patients, healthcare professionals, and policy makers without the necessary proof they need to make sound decisions regarding the use of cannabis as a medicine.

Sleep 95

Sleep Edibles DEA Policy 95

Veriheal

DECEMBER 28, 2021

D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. For example, pharmaceutical-grade cannabis is being sold across the fast-evolving retail pharmacy landscape.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

JUNE 20, 2019

The marijuana or cannabis plant contains more than 400 different chemicals and 60 cannabinoid compounds, all of which are absorbed when the whole leaf is smoked or ingested. The compound responsible for the euphoric, mind-altering effect is tetrahydrocannabinol (THC). One such compound being widely marketed is CBD oil.

THC 74

THC CBD Oil DEA 74

Cannabis Law Report

AUGUST 23, 2021

CBD is the main nonintoxicating phytocannabinoid, and unlike THC, CBD has a very low affinity for CB receptors of the endocannabinoid system and possesses the unique ability to counteract the intoxicating and adverse effects of cannabis, such as anxiety, tachycardia, hunger, and sedation in rats and humans.

Pets 105

Pets Hemp CBD Food 105

MedicalJane

JUNE 29, 2018

Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed. The Next Move Is On The DEA. Epidiolex’s launch is in the hands of the DEA. Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

SpeedWeed

JULY 23, 2021

We’re interested in how cannabinoids affect the nervous system, the brain, and in particular, we’re very interested in Alzheimer’s disease,” said Dr. Tyrell Towle, director of chemistry and extraction at MedPharm. Denver Company Moves Forward with Research License . Denver’s MedPharm Drives Research Further. “We

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

SpeedWeed

AUGUST 12, 2021

The FDA objected to the application, pointing out that just a few years ago it had already sent CBD down the path of active ingredients in pharmaceutical drugs—putting the cannabinoid at odds with the ingestible food and beverage and dietary supplement market.

CBD 52

CBD Pharmaceutical DEA Food 52

SpeedWeed

MARCH 28, 2021

It was also unique because it used whole-plant cannabis, rather than single-molecule extracts or synthetic pharmaceutical cannabinoids. . MAPS has been trying to get approved for a cultivation license for almost 20 years and filed a lawsuit in December 2020 against the DEA.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

Cannabis Info

MARCH 21, 2019

There are numerous companies providing ancillary services to the industry, as well as many derivative plays, like pharma and biotech companies making cannabinoid-based drugs and service/product providers that used to operate outside the marijuana industry but have gotten on board since legalization. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH).

Marijuana 59

Marijuana Pharmaceutical Hash Cannabinoids 59

Cannabis Law Report

APRIL 1, 2019

Selling dried cannabis to pharmaceutical companies as well as Cannabidiol (CBD) and Tetrahydrocannabinol (THC) extracts as soon as it is licensed, is the intention of Thailand’s tobacco authority among new measures to turn a profit on its dwindling cigarette business. 49 Percent Foreign Shareholding Allowed. GPO, the Ultra-Modern Drug Maker.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials DEA 40

Cannabis Law Report

AUGUST 12, 2022

Mainstreaming Cannabinoids – Path To Legalization. Obtaining DEA License to Grow Psilocybin Mushrooms. As research on the therapeutic potential of certain psychedelics expands, there are looming questions about where the pharmaceutical industry might fit in—and the possible corporatization and consolidation that could come with that.

Research and Development 52

Research and Development Topical Events Policy 52

Cannabis Law Report

OCTOBER 14, 2021

The study, conducted independently by Colorado State University researchers and published in the peer-reviewed, open-access scientific journal Pharmaceuticals , explored the pharmacokinetics of edible THC. At Ripple, our mission is to improve people’s lives through cannabinoids.

THC 40

THC Edibles Cannabinoids Data 40

Cannabis Law Report

JANUARY 11, 2019

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. While the DEA is now officially out of the hemp regulation business, the U.S.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

SpeedWeed

DECEMBER 28, 2018

Marinol (synthetic THC) has been available by prescription since 1986, and other synthetic cannabinoid drugs are in the works, but Epidiolex is the first plant-derived pharmaceutical to reach the US market. What would you call someone who spends $32,500 a year on cannabis that doesn’t get you high?

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. percent on a dry weight basis.”

Cannabinoids 143

Cannabinoids Hemp THC Safety 143

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We BRC) told The Cannigma this week. Junk’ cannabis ‘ill-suited for clinical trials’. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Canna Law Blog

JULY 25, 2020

Due to its high English speaking population, its significant diaspora in the United States, and its strong pharmaceutical industry that is already tied to the United States, the Philippines is an attractive cannabis participant, both as part of the supply chain and as a potential sales market. FDA and DEA.

Supply Chain 98

Supply Chain DEA Legislation Hemp 98

Veriheal

AUGUST 31, 2020

Essay Summary: Although doctors’ offices are full of pamphlets and flyers about mainstream pharmaceuticals in both English and Spanish, there is a lack of information for Hispanic patients seeking relief with cannabis and CBD. . Essay: “Combining Social Sciences and Pharmacology to Make a Positive Social Impact in Cannabis” .

Research and Development 119

Research and Development Education Agriculture Patients 119

Veriheal

MAY 4, 2022

Although the importance of carrying out additional studies on the subject of cannabis and heart health cannot be ignored, consumers shouldn’t necessarily refrain from loading up on the plant’s active cannabinoids. Drug Enforcement Agency (DEA). Cannabis and Heart Health: What Did the Researchers Discover?

Research and Development 98

Research and Development Consumption Vaping Edibles 98

Canna Law Blog

NOVEMBER 12, 2020

On October 27, the New York Department of Health (the “ DOH ”) released much anticipated proposed rules to regulate the processing, manufacturing, sale and marketing of cannabinoid hemp products in the state (the “ Rules ”). Broad spectrum means “a concentrate extracted from hemp containing multiple cannabinoids, but where all ?

Hemp 57

Hemp Extraction Cannabinoids Concentrates 57

SpeedWeed

JULY 28, 2021

“Colombia starts to play big, and with this decree we are putting ourselves at the forefront in terms of regulatory competitiveness, at least in Latin America and the Caribbean,” Duque said , acknowledging a move past the pharmaceutical market. “We million sq. Colombia is poised to become a major exporter of medical cannabis in Latin America.

Legalization 52

Legalization Seed-To-Sale Pharmaceutical Research and Development 52

SpeedWeed

APRIL 1, 2021

While every crop requires a cannabinoid test to establish its identity as hemp rather than marijuana, the federal government and all but a handful of states have been silent. Since the edible had a low overall concentration of cannabinoids, it didn’t cross the 0.3%

THC 52

THC Hemp CBD Vaping 52

SpeedWeed

MARCH 25, 2021

One group smoked flower with 12 percent THC content, another smoked flower with 11 percent CBD and almost no THC, a third group smoked a balanced blend with 8 percent THC and CBD, and the final group smoked a placebo with no active cannabinoids. The researchers found no significant difference between any of the cannabis blends or the placebo.

DEA 52

DEA Clinical Trials THC Pharmaceutical 52

Weedistry

MARCH 7, 2019

Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find. Investigators at St.

THC 40

THC CBD Clinical Trials Research and Development 40

SpeedWeed

AUGUST 19, 2021

It has been called “the psychedelic cannabinoid” for its borderline hallucinatory effects. And now that delta-8 THC , its trendy cousin, has been outlawed in some states across the country and flagged by the DEA , THC-O’s star may rise even faster. . THC-O didn’t appear on the DEA’s radar until nearly 30 years later.

THC 40

THC Hemp Extraction Vaping 40

SpeedWeed

MARCH 18, 2021

A fourth group received a placebo with almost zero active cannabinoids. Wasn’t the DEA going to let others grow research-grade cannabis? Is it any wonder why millions prefer cannabis over deadly pharmaceuticals and other harmful substances? Another group received an 11% CBD product with minimal THC. Participants were given 1.8

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

The Cannigma

SEPTEMBER 12, 2021

There are a lot of different molecules in nature, and though cannabinoids are rather rare, they are extremely abundant in cannabis (hence the name). THC is the most prevalent, famous and researched cannabinoid by far. What is THC? THC is short for tetrahydrocannabinol.

THC 98

THC Research and Development Cannabinoids CBD 98

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program. Dr. Sue Sisley. Later that night, everyone celebrated at a hotel bar.

DEA 234

DEA Research and Development Clinical Trials Patients 234

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. The Drug Enforcement Administration (DEA) announced annual quotas for the manufacture of controlled substances for research purposes, providing for 7,000 pounds of cannabis to be used in scientific studies. India’s Ministry of Finance has sanctioned research on cannabinoids.

Vaping 40

Vaping Banking Research and Development DEA 40